SCHEMBL18030924

SCHEMBL18030924

Cn1c2ccccc2c2c(C#N)c(C#N)ccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.51
▸ SRC P12931 1/20 0.51
▸ IMPDH2 P12268 1/20 0.47
▸ GPR3 P46089 1/20 0.47
▸ ALDH1A1 P00352 7/20 0.46
▸ HSD17B10 Q99714 3/20 0.46
▸ TSHR P16473 2/20 0.46
▸ NQO2 P16083 1/20 0.44
▸ NPSR1 Q6W5P4 3/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ GAA P10253 2/20 0.43
▸ CYP11B2 P19099 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ GLA P06280 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ LMNA P02545 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20115859 0.84 IMPDH2 (0.47) EGFRSRCIMPDH2GPR3ALDH1A1
SCHEMBL18030919 0.81 GPR3 (0.52) EGFRSRCIMPDH2GPR3ALDH1A1
SCHEMBL18030949 0.77 EGFR (0.51) EGFRSRCIMPDH2GPR3ALDH1A1
SCHEMBL18030937 0.77 KDM4E (0.50) EGFRSRCIMPDH2GPR3ALDH1A1
SCHEMBL14313953 0.76 GPR3 (0.71) GPR3ALDH1A1HSD17B10NQO2L3MBTL1
SCHEMBL24211213 0.76 EGFR (0.47) EGFRSRCIMPDH2GPR3ALDH1A1
SCHEMBL24278996 0.75 EGFR (0.36) EGFRSRCIMPDH2GPR3ALDH1A1
SCHEMBL20115855 0.73 KDM4E (0.68) EGFRSRCIMPDH2GPR3ALDH1A1
SCHEMBL18030933 0.73 IMPDH2 (0.46) EGFRSRCIMPDH2GPR3ALDH1A1
SCHEMBL18365441 0.73 EGFR (0.62) EGFRSRCIMPDH2GPR3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3061759-B1 NITRILE SUBSTITUTED DIBENZOFURANS IDEMITSU KOSAN CO (JP) 2019-12-25 — — EP disclosed
US-20170098781-A1 NEW DIBENZOFURANS AND DIBENZOTHIOPHENES IDEMITSU KOSAN CO., LTD. (JP) 2017-04-06 — — US disclosed
EP-3061759-A1 NITRILE SUBSTITUTED DIBENZOFURANS Idemitsu Kosan Co., Ltd (JP) 2016-08-31 — — EP disclosed
US-20160248026-A1 NITRILE SUBSTITUTED DIBENZOFURANS IDEMITSU KOSAN CO., LTD. (JP) 2016-08-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170098781-A1 NEW DIBENZOFURANS AND DIBENZOTHIOPHENES DBF4, DDT, SLC43A3 EGFR 2331/4885SRC 3464/4885IMPDH2 1250/4885
US-20160248026-A1 NITRILE SUBSTITUTED DIBENZOFURANS DBF4, NXF1, NCF1 EGFR 2124/4885SRC 3192/4885IMPDH2 2051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback